IGFBP7 and acute kidney injury: In the present study, we demonstrated that urinary biomarkers [TIMP-2]*[IGFBP-7] were generally elevated at ICU admission and within the first 48 h in a population of critically ill COVID-19 patients with a high prevalence of AKI.